American Well Corporation Class A Common Stock (AMWL)

FairStock Score: 56/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses that earn money consistently and sell below intrinsic value. Amwell does not yet fit. In fiscal 2025, the year ended 2025-12-31, revenue was $249.3M and net loss was $95.7M. In fiscal 2024, revenue was $254.4M and net loss was $208.1M. In fiscal 2023, revenue was $259.0M and net loss was $675.2M. Revenue is drifting down, and the company has lost money in each of the last four years, so the supplied Lynch category is none. The latest filed quarter, fiscal Q2 2026 ended 2026-06-30, had revenue of $52.0M and net loss of $9.9M. That loss is smaller than the fiscal Q2 2025 net loss of $19.7M, but revenue in fiscal Q2 2025 was $70.9M, so the sales base has shrunk. Free cash flow remains negative: trailing twelve month FCF was -$32.0M, and the FairStock FCF yield is -15.7%. The balance sheet has low debt, with D/E of 0.01, but the FairStock Altman Z-Score is -6.89, suggesting distress, and the Piotroski F-Score is 5/9. At the close on 2026-10-13, the price was $12.17, market cap $204.0M, and P/B 0.93. A below-book price can be interesting, but FairStock calculations show ROE of -29.12% and ROCE of -12.65%; equity is not compounding. Until revenue stabilizes and free cash flow turns positive, this is a speculative turnaround, not a value investment. I would want evidence of durable demand and lower cash burn before calling it cheap.

In plain English: American Well makes software that helps doctors and hospitals deliver virtual and hybrid healthcare visits. The business is losing money, revenue has been shrinking, and it uses cash, so the business looks weak. At $12.17, the stock trades below the value of its assets minus debts on paper, but because there are no profits it is hard to call the price cheap or fair; it looks like a risky turnaround.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer